# Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

> clinical trial · VERIFIED · 2026-07-13

Status: COMPLETED · Sponsor: Respira Therapeutics, Inc. · Condition: Pulmonary Arterial Hypertension

- Company: Respira Therapeutics, Inc.
- Sector: Pulmonary Arterial Hypertension
- Primary source: https://clinicaltrials.gov/study/NCT04266197

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.